From compliance to confidence: The 5 values of trust by design
How a unified approach to security, privacy, and AI governance builds trust in clinical trials
Summary
A unified governance framework built on ISO 27001 (security), ISO 27701 (privacy), and ISO 42001 (AI management) enables clinical trial organizations to move from basic compliance to demonstrable trust. By integrating these standards into a single system, sponsors can ensure that data is protected, patient privacy is respected, and AI is applied responsibly. This “trust by design” approach creates scalable, efficient, and transparent governance – helping organizations meet regulatory expectations while strengthening credibility with sponsors and patients in increasingly complex, AI‑driven trials.
In today’s clinical trial environment, trust is not assumed – it is earned
Sponsors, regulators, and patients expect not only that clinical trial data is accurate, but also that it is secure, private, and that AI tools are applied responsibly throughout the trial. As trials become more complex and AI-driven, governance frameworks must evolve to keep pace and build stakeholder trust.
This is where the combined power of ISO 27001 (information security), ISO 27701 (privacy), and ISO 42001 (AI management) comes into play. Individually, each standard addresses a critical risk area. Together, they are a unified governance foundation that forms the gold standard for compliance and trust.
Below are the top five values that a unified governance approach deliver for clinical trial organizations.
1. Security, privacy, and AI governance designed as one system
Too often, governance frameworks are built in silos: security here, privacy there, emerging technology governance somewhere else. An integrated ISO approach aligns these disciplines under a single management system, ensuring that:
- ISO 27001 safeguards sensitive clinical trial data
- ISO 27701 protects personal and patient data in compliance with global legal standards
- ISO 42001 governs the responsible application of advanced analytics and AI tools
This unified structure reduces compliance gaps, inconsistencies, and duplication, and replaces fragmented oversight with end-to-end trust by design.
2. Trust that is demonstrable, not declared
In clinical research, trust must be earned. ISO certifications provide third-party validation that governance is not aspirational or theoretical; rather, it is foundational to how data and systems are managed every day. But the real value comes when certifications work together, reinforcing one another.
With a combined ISO framework, organizations can empirically demonstrate:
- How data is protected (security)
- How personal data rights are respected (privacy)
- How AI systems are governed, monitored, and accountable
This turns trust into something tangible sponsors can evaluate objectively and rely on.
3. Scalable governance that grows with the trial portfolio
Clinical trials don’t remain static. They scale in size, complexity, geography, and data volume. By sharing common principles such as risk assessment, oversight, and continuous improvement, ISO 27001, ISO 27701, and ISO 42001 enable governance to scale without reinvention.
Key advantages include:
- Consistent controls across platforms and studies
- Faster onboarding of new systems and processes
- Reduced friction as expectations evolve across sponsors, regulatory authorities, site partners, and participants
This scalability allows oversight and innovation to grow at the same pace.
4. Operational efficiency through a unified certification strategy
Maintaining multiple certifications can be resource-intensive, unless the certifications are intentionally integrated. By aligning audits, evidence collection, and risk management activities across the various certifications, organizations can operate on an “audit once, certify many” principle.
The result:
- Less audit fatigue for internal teams
- More efficient use of time and expertise
- Clear accountability across security, privacy, and technology governance
Instead of slowing teams down, governance becomes a repeatable, efficient operating model.
5. Governance that creates differentiation
Strong governance is no longer just about meeting regulatory expectations. It defines how a clinical trial vendor is selected by clinical trial sponsors as long-term partners. Organizations that can show how security, privacy, and emerging technology governance are structurally connected send a powerful signal to sponsors:
The result:
- Risk is understood and managed holistically
- Patient data is protected and handled in a compliant manner
- Innovation is controlled, transparent, and sustainable
In an increasingly crowded clinical research landscape, this level of credibility becomes a deciding factor in long-term partnerships.
A unified ISO framework for the future of clinical trials
ISO 27001, ISO 27701, and ISO 42001 are more than certifications – they are the building blocks of modern clinical trial governance.
When implemented together, they create a framework that protects data, respects individuals, and enables responsible innovation, all while supporting scale and efficiency.
Governance done right is no longer a checkbox. It’s a strategic advantage, and a foundation for trust in every trial.
Interested in more?
In a recent LinkedIn Live, Trust by design: Privacy, security, and responsible AI in clinical trials, Clario experts explored how a unified data governance strategy can build sponsor confidence across modern clinical trials. The discussion highlighted how ISO 27001 (information security), ISO 27701 (privacy protection), and ISO 42001 (AI management) certifications work together to form a comprehensive framework for protecting sensitive trial data, safeguarding patient privacy, and enabling responsible AI. Together, these standards reinforce one another to meet the growing expectations of sponsors and regulatory bodies.
Watch the LinkedIn Live on LinkedIn.com to learn more.